policy
UNDER REVIEWJudicious therapeutic use of antimicrobials in aquatic animal medicine
Aquatic animal veterinarians should use all therapeutants, including antimicrobials, judiciously to restore aquatic animal health, ensure continued…
policy
UNDER REVIEWUse of aquatic animal therapeutic agents
The AVMA recognizes the need for sufficient approved therapeutics to facilitate safe and effective prevention, diagnosis, treatment and control of…
policy
UNDER REVIEWNonhuman primates as assistance animals
The AVMA does not support the use of nonhuman primates as assistance animals because of animal welfare concerns, the potential for serious injury, and…
policy
UNDER REVIEWJudicious therapeutic use of antimicrobials
Judicious therapeutic use of antimicrobials is a core principle of the broader goal of antimicrobial stewardship.
policy
UNDER REVIEWAABP judicious therapeutic use of antimicrobials in cattle
The AVMA has endorsed these guidelines developed by the American Association of Bovine Practitioners.
policy
UNDER REVIEWBest management practices for pharmaceutical disposal
Pharmaceutical disposal is an important and complex issue. See best practices for veterinarians and veterinary teams.
policy
American Association of Equine Practitioners (AAEP) judicious use of antimicrobials guidelines
The AVMA has endorsed these antimicrobial stewardship guidelines developed by the American Association of Equine Practitioners.
policy
Approval and availability of antimicrobials for use in food-producing animals
The availability and effectiveness of antimicrobials, including medically important antimicrobials, are important to support the health and welfare of…
policy
Vaccination principles
Vaccines have been proven highly efficacious and beneficial to the health of veterinary patients, as well as the general public. Decisions about…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
policy
Aminoglycoside use in cattle and small ruminants
The AVMA does not support extralabel use of aminoglycosides in cattle or small ruminants due to the substantial risk for violative residues in food…
policy
Annual rabies vaccination waiver
Waivers of rabies vaccination should only be issued with approval from the appropriate public health authorities upon recommendation from a licensed…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Extralabel use of medicated feeds, including veterinary feed directive drugs, for minor species
The AVMA supports regulatory discretion in enforcing extralabel use of medicated feeds in minor species under veterinary oversight.
policy
Inappropriate requests for Drug Enforcement Administration (DEA) registration numbers
The AVMA strongly opposes the use of DEA registration numbers for any purpose other than the one for which it was intended: to provide certification…
policy
Joint AVMA-FVE-CVMA statement on responsible and judicious use of antimicrobials
The AVMA, Federation of Veterinarians of Europe, and Canadian Veterinary Medical Association have jointly adopted this policy on responsible and…
policy
Limited prohibition on extralabel drug use
Any regulatory prohibition of extralabel drug use in animals should be science-based and as limited in scope as possible, consistent with protecting…
policy
National Antimicrobial Resistance Monitoring System (NARMS)
The AVMA recognizes the National Antimicrobial Resistance Monitoring System (NARMS) as a resource for information on antimicrobial resistance trends…
policy
Organic foods
Food producers should be encouraged to provide medically necessary therapy, including antimicrobials, under a veterinarian’s direction, regardless of…
policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Therapeutic medications in racehorses
Health care decisions for individual horses are the responsibility of the veterinarian, trainer, and owner and must have the best interests of the…
policy
Therapeutic medications in competition equids
The AVMA condemns the administration of non-therapeutic or unprescribed medications to competition equids. Health care decisions regarding individual…
policy
Representation to the United States Pharmacopeial Convention (USP)
The AVMA encourages expansion of veterinary membership to the USP, such as representation of veterinary pharmacologists.
policy
Restriction of veterinary biologics to veterinarians' use
The AVMA supports USDA efforts to restrict all veterinary biologics used in disease control programs, those with high incidence of reactions, and…